Baxter International Inc (BAX)
41.02
+0.62
(+1.52%)
USD |
NYSE |
Apr 23, 16:00
41.02
0.00 (0.00%)
After-Hours: 20:00
Baxter International Research and Development Expense (Quarterly): 172.00M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 172.00M |
| September 30, 2023 | 166.00M |
| June 30, 2023 | 165.00M |
| March 31, 2023 | 164.00M |
| December 31, 2022 | 154.00M |
| September 30, 2022 | 151.00M |
| June 30, 2022 | 148.00M |
| March 31, 2022 | 150.00M |
| December 31, 2021 | 135.00M |
| September 30, 2021 | 129.00M |
| June 30, 2021 | 139.00M |
| March 31, 2021 | 128.00M |
| December 31, 2020 | 135.00M |
| September 30, 2020 | 123.00M |
| June 30, 2020 | 117.00M |
| March 31, 2020 | 146.00M |
| December 31, 2019 | 156.00M |
| September 30, 2019 | 144.00M |
| June 30, 2019 | 166.00M |
| March 31, 2019 | 129.00M |
| December 31, 2018 | 175.00M |
| September 30, 2018 | 166.00M |
| June 30, 2018 | 174.00M |
| March 31, 2018 | 140.00M |
| December 31, 2017 | 183.00M |
| Date | Value |
|---|---|
| September 30, 2017 | 150.00M |
| June 30, 2017 | 155.00M |
| March 31, 2017 | 127.00M |
| December 31, 2016 | 156.00M |
| September 30, 2016 | 159.00M |
| June 30, 2016 | 195.00M |
| March 31, 2016 | 136.00M |
| December 31, 2015 | 161.00M |
| September 30, 2015 | 148.00M |
| June 30, 2015 | 151.00M |
| March 31, 2015 | 143.00M |
| December 31, 2014 | 156.00M |
| September 30, 2014 | 149.00M |
| June 30, 2014 | 322.00M |
| March 31, 2014 | 309.00M |
| December 31, 2013 | -187.00M |
| September 30, 2013 | 277.00M |
| June 30, 2013 | 273.00M |
| March 31, 2013 | 246.00M |
| December 31, 2012 | 216.00M |
| September 30, 2012 | 290.00M |
| June 30, 2012 | 306.00M |
| March 31, 2012 | 269.00M |
| December 31, 2011 | 254.00M |
| September 30, 2011 | 239.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
117.00M
Minimum
Jun 2020
172.00M
Maximum
Dec 2023
146.74M
Average
148.00M
Median
Jun 2022
Research and Development Expense (Quarterly) Benchmarks
| Becton Dickinson & Co | 290.00M |
| LeMaitre Vascular Inc | 4.351M |
| Integer Holdings Corp | 13.26M |
| Outset Medical Inc | 12.53M |
| Perspective Therapeutics Inc | 6.08M |